炎琥宁注射液联合γ-干扰素雾化吸入治疗新生儿呼吸道合胞病毒肺炎

Treating Neonatal Respiratory Syncytial Virus Pneumonia by Aerosol Inhalation with Yanhuning Injection and γ-Interferon

目的:总结炎琥宁注射液与γ-干扰素雾化吸收联合用药治疗新生儿呼吸道合胞病毒肺炎的临床疗效。方法:选取60例新生儿呼吸道合胞病毒肺炎患儿随机分为治疗组(炎琥宁联合干扰素组)、对照组(炎琥宁组),用药7天评价疗效。观察咳嗽、喘憋、肺部体征及X线胸片变化等。结果:两组总疗效比较:联合干扰素组愈显率83.3%,总有效率97.0%:常规组愈显率65.5%,总有效率85.7%。结论:炎琥宁注射液联合γ-干扰素雾化吸入可明显缩短咳嗽、喘憋时间,缩短肺部X线改变恢复时间,从而缩短病程、挺高疗效。

Objective： To summarize Yanhuning（Hu） injection and atomization absorption of γ-interferon combination therapyin treating neonatal respiratory syncytial virus pneumonia in clinical efficacy. Methods： 60 cases of neonatal respiratory syncytial virus pneumonia were randomly divided into treatment group （Hu in combination with interferon group）, the controi group （Hu group）, medication 7 days were evaluated. Observed coughing, asthmatic, pulmonary signs and X-ray changes. Results： The overall efficacy of the two groups comparison： in combination with interferon group markedly effective rate was 83.3%, with a total effective rate 97.0%; routine group markedly effective rate 65,5%, with a total effective rate was 85.7%. Conclusion： Hu and γ-interferon injection aerosol inhalaion can significantly reduce the cough, Asthmatic time, lung X-ray changes to shorten recovery time, thus shortening the course of the disease, improve the curative effect.